دورية أكاديمية
أعرض في EDS

Research design and baseline participant characteristics of the Resilient, Empowered, Active Living with Diabetes - Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes.

التفاصيل البيبلوغرافية
العنوان: Research design and baseline participant characteristics of the Resilient, Empowered, Active Living with Diabetes - Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes.
المؤلفون: Pyatak EA; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America. Electronic address: beth.pyatak@usc.edu., Ali A; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Khurana AR; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Lee PJ; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Sideris J; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Fox S; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, United States of America., Diaz J; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Granados G; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Blanchard J; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., McGuire R; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Salazar Plascencia E; Alpha Clinic, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America., Salcedo-Rodriguez E; Children's Hospital Los Angeles, Los Angeles, CA, United States of America., Flores-Garcia J; Children's Hospital Los Angeles, Los Angeles, CA, United States of America., Linderman M; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Taylor EE; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Tapia V; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Nnoli N; Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, United States of America., Sequeira PA; Department of Endocrinology, Los Angeles General Medical Center, Los Angeles, CA, United States of America., Freeby MJ; David Geffen UCLA School of Medicine, Los Angeles, CA, United States of America., Raymond JK; Alpha Clinic, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
المصدر: Contemporary clinical trials [Contemp Clin Trials] 2023 Dec; Vol. 135, pp. 107386. Date of Electronic Publication: 2023 Nov 04.
نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, N.Y. : Elsevier, c2005-
مواضيع طبية MeSH: Diabetes Mellitus, Type 1*/epidemiology , Diabetes Mellitus, Type 1*/therapy , Telemedicine*, Humans ; Young Adult ; Quality of Life ; Pandemics ; Research Design ; Blood Glucose/analysis
مستخلص: Background: Type 1 diabetes (T1D) is a chronic condition affecting nearly 1.9 million people in the United States. Young adults (YAs) with T1D face unique challenges in managing their condition, experiencing poorer health and well-being than other age groups. The current study is evaluating the Resilient, Empowered, Active Living (REAL) intervention, previously shown to improve glucose levels and quality of life among YAs with diabetes, using telehealth delivery (REAL-T) to expand reach and accessibility. This paper reports on the methodology and baseline participant characteristics of the REAL-T study.
Methods: REAL-T is a two-arm randomized controlled trial that recruited 18-30 year olds with T1D via clinics and social media advertising. Data collection, which was adapted to be fully remote due to COVID-19, occurs every three months for one year. Participants receive either usual care or a 6-month telehealth occupational therapy intervention. The primary outcome is glycated hemoglobin (A1c); secondary outcomes include diabetes distress, quality of life, and continuous glucose monitor-derived measures.
Results: The study enrolled a diverse sample of 209 YAs with T1D. Analysis of baseline data indicates equivalence between the intervention and control groups. Study participants have notably higher diabetes distress and poorer mental well-being than similar populations.
Conclusion: The REAL-T study successfully adapted to remote implementation during the COVID-19 pandemic. By examining long-term outcomes, mediating pathways, and cost-effectiveness, the study will contribute knowledge of the impact of tailored interventions for YAs with T1D, designed to reduce disparities and improve health and well-being in this population.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023. Published by Elsevier Inc.)
References: J Clin Endocrinol Metab. 2020 Aug 1;105(8):. (PMID: 32382736)
OTJR (Thorofare N J). 2023 Jul;43(3):426-434. (PMID: 37165993)
PLoS One. 2017 May 10;12(5):e0177210. (PMID: 28489876)
Diabetes Care. 2003 May;26(5):1641-2. (PMID: 12716841)
AIDS Behav. 2008 Jan;12(1):86-94. (PMID: 17577653)
AIDS Behav. 2014 Dec;18(12):2349-58. (PMID: 24077970)
Diabetes Technol Ther. 2021 Apr;23(4):306-313. (PMID: 33155826)
Diabet Med. 2018 Jul;35(7):846-854. (PMID: 29577410)
Curr Diabetes Rev. 2015;11(4):239-50. (PMID: 25901502)
Diabet Med. 2014 Feb;31(2):227-31. (PMID: 23952498)
Diabetes Care. 2018 Apr;41(4):696-704. (PMID: 29351961)
Diabetes Care. 2011 Nov;34(11):2477-85. (PMID: 22025785)
Health Educ Res. 2007 Oct;22(5):691-702. (PMID: 17138613)
J Diabetes Sci Technol. 2023 Mar;17(2):322-328. (PMID: 34632823)
Pediatr Diabetes. 2021 Mar;22(2):345-353. (PMID: 33034097)
J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686)
Diabet Med. 2020 Sep;37(9):1427-1442. (PMID: 31968127)
Am J Occup Ther. 2022 Sep 1;76(5):. (PMID: 36053733)
Telemed J E Health. 2014 Nov;20(11):997-1003. (PMID: 25272141)
Diabet Med. 2019 Jul;36(7):836-846. (PMID: 30761589)
Health Qual Life Outcomes. 2020 May 12;18(1):137. (PMID: 32398086)
Clin Diabetes Endocrinol. 2019 Mar 6;5:3. (PMID: 30891310)
Ann Behav Med. 2022 May 18;56(5):461-471. (PMID: 34570884)
Aust Health Rev. 2020 Aug;44(4):601-608. (PMID: 32600522)
Diabet Med. 2018 Feb;35(2):203-213. (PMID: 29171084)
J Diabetes Sci Technol. 2012 Mar 01;6(2):380-6. (PMID: 22538150)
Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. (PMID: 36493795)
Clin Trials. 2020 Dec;17(6):664-674. (PMID: 32627589)
Diabetes Technol Ther. 2020 Sep;22(9):645-650. (PMID: 31905008)
Clin Pediatr (Phila). 2013 Jan;52(1):10-5. (PMID: 22988007)
J Diabetes Sci Technol. 2023 Sep;17(5):1226-1242. (PMID: 35348391)
Diabetes Care. 2005 Mar;28(3):626-31. (PMID: 15735199)
Can J Occup Ther. 1990 Apr;57(2):82-7. (PMID: 10104738)
Value Health. 2018 Apr;21(4):432-440. (PMID: 29680100)
JAMA. 2017 Feb 28;317(8):825-835. (PMID: 28245334)
Int J Behav Nutr Phys Act. 2012 Aug 30;9:102. (PMID: 22935297)
Diabetes Technol Ther. 2019 Feb;21(2):66-72. (PMID: 30657336)
Front Clin Diabetes Healthc. 2022 Jan 13;2:823046. (PMID: 36994332)
Science. 2021 Jul 30;373(6554):522-527. (PMID: 34326234)
Diabetes Res Clin Pract. 2021 Oct;180:109066. (PMID: 34563586)
معلومات مُعتمدة: R01 DK116719 United States DK NIDDK NIH HHS
فهرسة مساهمة: Keywords: Lifestyle intervention; Occupational therapy; Randomized controlled trial; Type 1 diabetes; Young adults
المشرفين على المادة: 0 (Blood Glucose)
تواريخ الأحداث: Date Created: 20231106 Date Completed: 20231128 Latest Revision: 20240521
رمز التحديث: 20240522
مُعرف محوري في PubMed: PMC10846480
DOI: 10.1016/j.cct.2023.107386
PMID: 37931702
قاعدة البيانات: MEDLINE
الوصف
تدمد:1559-2030
DOI:10.1016/j.cct.2023.107386